help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arnold, S. F.
Right arrow Articles by Sasson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnold, S. F.
Right arrow Articles by Sasson, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Molecular Endocrinology 11 (1): 48-53
Copyright © 1997 by The Endocrine Society

Estradiol-Binding Mechanism and Binding Capacity of the Human Estrogen Receptor Is Regulated by Tyrosine Phosphorylation

Steven F. Arnold1, Michal Melamed, Daria P. Vorojeikina, Angelo C. Notides and Shlomo Sasson2

Departments of Environmental Medicine and Biophysics (S.F.A., D.P.V., A.C.N.) University of Rochester School of Medicine and Dentistry Rochester, New York 14642
Department of Pharmacology (M.M., S.S.) Hebrew University of Jerusalem Faculty of Medicine, School of Pharmacy Jerusalem, 91120, Israel

We have investigated the effects of tyrosine phosphorylation on the estradiol-binding mechanism and binding capacity of the human estrogen receptor (hER). The wild type hER and a point mutant form of the hER, in which tyrosine 537 was mutated to phenylalanine (Y537F hER), were expressed in Sf9 insect cells. The wild type hER, but not the Y537F hER, reacted with a anti-phosphotyrosine monoclonal antibody, indicating that tyrosine 537 was the only tyrosine phosphorylated on the hER. Scatchard and Hill analyses of the the binding interaction of [3H]estradiol with the wild type hER indicated that the addition of millimolar phosphotyrosine, but not tyrosine, phosphate, or phosphoserine, abolished the cooperative binding mechanism of the hER. These observations are consistent with the idea that phosphotyrosine blocks dimerization and site-site interactions between the hER monomers. The wild type hER bound 10-fold more [3H]estradiol than the Y537F hER. Treatment of the purified wild type hER with a tyrosine phosphatase decreased the binding capacity of the hER by approximately 90%, whereas, a serine/threonine phosphatase had no effect. The estrogen-binding capacity of the tyrosine-dephosphorylated hER was completely restored by rephosphorylation of tyrosine 537 with p60c-src, a tyrosine kinase. These results indicate that p60c-src can restore estrogen binding to the tyrosine-dephosphorylated hER and that dimerization and cooperative site-site interaction of the hER occur via a phosphotyrosine-binding interaction.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Li, K. Hisamoto, K. H. Kim, M. P. Haynes, P. M. Bauer, A. Sanjay, M. Collinge, R. Baron, W. C. Sessa, and J. R. Bender
Variant estrogen receptor c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation
PNAS, October 16, 2007; 104(42): 16468 - 16473.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Cheng, C. Zhang, and D. J. Shapiro
A Functional Serine 118 Phosphorylation Site in Estrogen Receptor-{alpha} Is Required for Down-Regulation of Gene Expression by 17{beta}-Estradiol and 4-Hydroxytamoxifen
Endocrinology, October 1, 2007; 148(10): 4634 - 4641.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
V. S. Likhite, F. Stossi, K. Kim, B. S. Katzenellenbogen, and J. A. Katzenellenbogen
Kinase-Specific Phosphorylation of the Estrogen Receptor Changes Receptor Interactions with Ligand, Deoxyribonucleic Acid, and Coregulators Associated with Alterations in Estrogen and Tamoxifen Activity
Mol. Endocrinol., December 1, 2006; 20(12): 3120 - 3132.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Kraus, D. Gioeli, T. Vomastek, V. Gordon, and M. J. Weber
Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor.
Cancer Res., November 15, 2006; 66(22): 11047 - 11054.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. C. Jordan
Pak up your breast tumor--and grow!
J Natl Cancer Inst, May 17, 2006; 98(10): 657 - 659.
[Full Text] [PDF]

Home page
 FASEB J.Home page
S. Mahmoodzadeh, S. Eder, J. Nordmeyer, E. Ehler, O. Huber, P. Martus, J. Weiske, R. Pregla, R. Hetzer, and V. Regitz-Zagrosek
Estrogen receptor alpha up-regulation and redistribution in human heart failure
FASEB J, May 1, 2006; 20(7): 926 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A.G.B. Hurst, D.W. Goad, M. Mohan, and J.R. Malayer
Independent Downstream Gene Expression Profiles in the Presence of Estrogen Receptor {alpha} or {beta}
Biol Reprod, October 1, 2004; 71(4): 1252 - 1261.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. X.-D. Song, R. A. McPherson, L. Adam, Y. Bao, M. Shupnik, R. Kumar, and R. J. Santen
Linkage of Rapid Estrogen Action to MAPK Activation by ER{alpha}-Shc Association and Shc Pathway Activation
Mol. Endocrinol., January 1, 2002; 16(1): 116 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson
Mechanisms of Estrogen Action
Physiol Rev, October 1, 2001; 81(4): 1535 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Demay, M. De Monti, C. Tiffoche, C. Vaillant, and M. L. Thieulant
Steroid-Independent Activation of ER by GnRH in Gonadotrope Pituitary Cells
Endocrinology, August 1, 2001; 142(8): 3340 - 3347.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. Feng, P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P. J. Kushner
Potentiation of Estrogen Receptor Activation Function 1 (AF-1) by Src/JNK through a Serine 118-Independent Pathway
Mol. Endocrinol., January 1, 2001; 15(1): 32 - 45.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
A. J. Bruce-Keller, J. L. Keeling, J. N. Keller, F. F. Huang, S. Camondola, and M. P. Mattson
Antiinflammatory Effects of Estrogen on Microglial Activation
Endocrinology, October 1, 2000; 141(10): 3646 - 3656.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Robyr, A. P. Wolffe, and W. Wahli
Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks
Mol. Endocrinol., March 1, 2000; 14(3): 329 - 347.
[Full Text]

Home page
 Mol. Cell. Biol.Home page
D. Chen, P. E. Pace, R. C. Coombes, and S. Ali
Phosphorylation of Human Estrogen Receptor alpha  by Protein Kinase A Regulates Dimerization
Mol. Cell. Biol., February 1, 1999; 19(2): 1002 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A.-M. Moilanen, U. Karvonen, H. Poukka, O. A. Jänne, and J. J. Palvimo
Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase
Mol. Biol. Cell, September 1, 1998; 9(9): 2527 - 2543.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
A. Revelli, M. Massobrio, and J. Tesarik
Nongenomic Actions of Steroid Hormones in Reproductive Tissues
Endocr. Rev., February 1, 1998; 19(1): 3 - 17.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society